Your search for ‘Fulbright & Jaworski LLP’ returned 961 results

Case: Novartis Pharmaceuticals Canada Inc. v. Cobalt Pharmaceuticals Company and the Minister of Health

In this case, the Federal Court dealt with a sui generis application by the Applicant, F. Hoffmann-La Roche AG, based on ss 53(2) of the Patent Act, who sought a declaration amending, or in the alternative, striking part of the disclosure of its own Canadian Patent No. 2,103,324 (the ‘324 Patent).